Contribution
My Lords, I have added my name to this amendment. The noble Baroness, Lady Young of Old Scone, who tabled it, cannot be here because she is chairing a Forestry Commission meeting in Bristol, so it falls on me to speak again. My interest in IBD comes from one of my sons, who has had it for nearly 20 years. His treatment has been excellent, from GP to Birmingham Children’s Hospital to Birmingham University hospital trust. Even when he moved to work in London for four or five years, he was allowed to continue treatment at Birmingham. The transition from children’s to adult services was excellent.
The frustration is that quality of care is so patchy throughout the country. In a sense, this almost repeats the debate led by the noble Lord, Lord Foster. The conundrum is why it is so patchy when IBD is such a major issue. We know that it is a lifelong, relapsing condition which affects more than half a million people across the UK. There are two main types of IBD: Crohn’s disease and ulcerative colitis. IBD currently impacts one in every 23 of the population. We know that prevalence is rising and that it disproportionately affects people of working age, with most patients diagnosed between the ages of 15 and 30. At that young age, it can have a devastating impact on their lives. We have had advances in treatment, but the variation in quality of care across the country is quite extraordinary and indefensible. We know that too many patients experience regular flares and poor disease control. If it is poorly controlled, IBD can have a profound impact on a person’s education, employment, family life and overall quality of life. Symptoms of the disease can be debilitating.
The NHS quality strategy rightly places quality improvement outcomes at the centre of health policy, but the issue is that the mechanism to drive accountability and improvement seems focused on a number of nationally prioritised conditions, and IBD is not regarded as a priority despite the half a million people affected by it. There are some really good programmes. NICE guidelines are very good, and Getting It Right First Time provides important guidance on what good care looks like, but, as we know, that does not always mean that you get a consistent approach. The GIRFT programme has identified substantial variation in the delivery of IBD care across the NHS, with clinical guidance and best practice not implemented consistently.
We know that IBD carries a high cost to the NHS, of approximately £3 billion a year. Patients with active disease cost the NHS three times more than patients in remission. As IBD commonly begins in early adulthood, poorly managed patients can then accumulate decades of healthcare usage. As I have already implied, it impacts a patient’s ability to work and to be productive at work, so it has a big impact on the economy.
In a sense, I feel sorry for my noble friend the Minister. As she knows, the scope of this Bill is wide and therefore we can have any amendment we like in relation to the provision of healthcare. We have taken advantage of that here, but this is a cry from the heart about the NHS. There are so many examples of this: in some parts of the country, as I saw in Birmingham, a brilliant service operates, but in other parts of the country, it is hopeless. Somehow, we do not seem able to get a grip on this. Even with programmes such as Get It Right First Time, it all seems vague. What I am asking for is some sense of the need to get a grip on these disease areas which have a huge impact on the economy, the health service and people’s lives. We need to say to the NHS, “Look, this patchy response is just unacceptable, because we know it can work well. We’d like to see it extended elsewhere”. I think that is what the noble Baroness, Lady Young, might have said. She would have said it with a good deal more assertiveness, but she would have said it. I beg to move.